Kapil Bharti, Phd

NIH, Maryland, United States

Dr. Kapil Bharti obtained his Ph.D. from J.W. Goethe University, Frankfurt, Germany, graduating summa cum laude. He did his postdoc at the National Institutes of Health. His lab at the National Eye Institute recently received started the first U.S. phase I/IIa trial to test autologous iPSC-derived RPE patch in AMD patients. Currently, he is co-developing a dual RPE/photoreceptor cell therapy with Opsis Therapeutics. He has won several awards including being the first Earl Stadtman Tenure Track Investigator at NEI, NIH Director’s award, NEI Director’s Dr. Karl Kupfer Visionary award, and 12th Sayer Vision Research lecture at NEI for his revolutionary work on developing ocular cell-therapies.

Disclosure information not submitted.

Presentation(s):

• 3D-Bioprinted Vascularized Eye Tissue Provides a Patient-Specific Model to Test Therapies for Inherited and Age-Related Macular Degenerations

  Monday, February 5, 2024
  10:30 AM – 11:00 AM EST